Omega-3’s are the most important and beneficial of all fatty acids, playing a key role in keeping your brain healthy.
The primary Omega-3 components, or acids, are known as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
They are classified as essential acids due to the fact that we need them for the proper functioning of the human body but we are not capable of producing them internally. In other words, they must be obtained from external sources like diet or supplementation.
Omega 3’s are noted for improving brain function in animal studies, though recent human studies have reported no observable effects. Some nootropic users will take a Fish Oil or Krill Oil supplement containing Omega 3’s as part of their stack, but if you eat a diet high in fish content this may be unnecessary.
These Omega-3 fatty acids and oils are normally found in the fat of cold-water fish. Additional sources include nut oils, plant oils, flaxseed, shellfish, and walnuts. Both DHA and EPA are considered to be long-chain fatty acids since they contain more than 16 carbon elements in their chemical makeup.
These should not be confused with Omega-6 fatty acids, which are considered to be short-chain fatty acids and are bad for the body in high amounts. A balance between Omega 3’s and Omega 6’s is considered the best strategy for optimal health.



- Exhibits anti-inflammatory effects
- Supports mood, memory & brain health
- Promotes cardiovascular health
Omega-3 Effects:
Related Topics
The main function and effect that Omega-3 fatty oils have on the body is that they help with cell membranes and their function.
They are essential in the repair, maintenance, and even growth and proper functioning of the membranes of every human cell.
These cell membranes are made up of a number of different types of fats called phospholipids and Omega-3 oils help to hold everything together. With their long-chain structure, this ensures that the cell walls do not become overly rigid.
The importance of the cell membrane cannot be overstated. This is almost like a control center for each individual human cell. What happens is that these membranes, or walls, determine which chemicals and materials are allowed to leave and enter the cell.
Ideally, the toxins and other waste materials are allowed to leave, while those needed for repair and maintenance are allowed to enter. They also help to determine the chemical messengers leaving and entering the cells.
This is especially important for the brain and nerve cells, since this effects the transmission of nerve impulses. Cell membranes which have become worn out and overly rigid make brain processes much less efficient, and it is even thought to be one of the biggest contributing factors to a number of degenerative cognitive disorders.
Some studies have found that using Omega 3 supplements may protect against dementia in elderly individuals, although results are inconclusive at this point.
Omega-3 Benefits:
The DHA found in Omega-3 is one of the most common types of lipids (or fatty acids) present in the brain. This is why Omega-3 is considered to be brain food.
With the proper level of DHA, some studies have shown that people have a reduced risk of developing brain issues later in life such as Alzheimer’s and other forms of dementia and age-related cognitive decline.
Also, research suggests that people who use Omega-3 supplements do have better overall cognitive functioning than those who do not.
This supplement has also been shown to help reduce brain shrinkage within the cerebral cortex and the hippocampus. There are also conflicting reports that suggest if you already receive an adequate intake of Omega 3’s from your diet that there will be limited benefits to taking additional supplements. However, if you are deficient in this nutrient then it may be important to use a Fish Oil supplement or something similar.
An incredibly important, but often overlooked, benefit of Omega-3 supplementation is that it reduces inflammation. Many times, all types of health problems and issues are non-specific in their cause. The problem in most of these cases can be traced back directly to inflammation. By using Omega-3’s you will see an overall reduction in the risk for most types of diseases and health concerns.
Omega-3’s are also known to help in the areas of insulin and heart function. Both glucose and fatty acid uptake into the muscle cells are increased, thereby sending more nutrients toward muscle cells and away from fat.
This can help to improve overall body composition. It helps to maintain proper insulin formation and secretion. Evidence further suggests that Omega-3 will increase cardiac output and even stroke volume of the heart, helping to support healthy blood flow.
Omega-3 Dosage:
If you decide to use a supplement to ensure you are getting the recommended amount of this ingredient, you should aim to consume anywhere between 1 and 4 grams of both EPA and DHA Omega-3 acids each day, combined.
Many experts suggest that taking these supplements with meals is more effective since they are fat-soluble, thinking that this may improve uptake and the anabolic response.
Omega-3 Side Effects:
Omega-3 usage is thought to be very safe, among the safest of all possible supplements, in fact. It is very well-tolerated in almost everyone. Despite these facts, there are some unusual side effects.
It should be noted that these are generally very rare and normal only present when taken in extremely high doses. These effects include GI distress and excessive bleeding. There may be some people who have allergic reactions to fish oil; if so, avoid Omega-3’s. You may also experience some foul tasting fish-like belches.
Omega-3 Review:
For many years, Omega-3 supplements were considered vital for improving brain function. While recent studies have now put this claim into question, there is no doubt that Omega-3’s are intimately connected with brain health and memory function. If you are already eating a diet with foods rich in essential fatty acids, then you may find limited cognitive enhancement benefits from using this supplement.
A better nutrient to look at would be Choline which is necessary for proper memory storage and recall. Over 90% of the population is deficient in choline and by using a choline supplement you can significantly improve reasoning, memory and learning abilities.
- Cooper RE, Tye C, Kuntsi J, Vassos E, Asherson P. Omega-3 polyunsaturated fatty acid supplementation and cognition: A systematic review and meta-analysis. J Psychopharmacol. 2015
- Yessoufou A, Nekoua MP, Gbankoto A, Mashalla Y, Moutairou K. Beneficial effects of omega-3 polyunsaturated Fatty acids in gestational diabetes: consequences in macrosomia and adulthood obesity. J Diabetes Res. 2015
- Dyall SC. Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Front Aging Neurosci. 2015
- Nestel P, Clifton P, Colquhoun D, Noakes M, Mori TA, Sullivan D, Thomas B. Indications for Omega-3 Long Chain Polyunsaturated Fatty Acid in the Prevention and Treatment of Cardiovascular Disease. Heart Lung Circ. 2015
- Pirillo A, Catapano AL. Update on the management of severe hypertriglyceridemia--focus on free fatty acid forms of omega-3. Drug Des Devel Ther. 2015
- de Aguiar Pastore Silva J, Emilia de Souza Fabre M, Waitzberg DL. Omega-3 supplements for patients in chemotherapy and/or radiotherapy: A systematic review. Clin Nutr. 2015
- Lei QC, Wang XY, Xia XF, Zheng HZ, Bi JC, Tian F, Li N. The role of omega-3 fatty acids in acute pancreatitis: a meta-analysis of randomized controlled trials. Nutrients. 2015
- McNamara RK, Vannest JJ, Valentine CJ. Role of perinatal long-chain omega-3 fatty acids in cortical circuit maturation: Mechanisms and implications for psychopathology. World J Psychiatry. 2015
- Blondeau N, Lipsky RH, Bourourou M, Duncan MW, Gorelick PB, Marini AM. Alpha-linolenic acid: an omega-3 fatty acid with neuroprotective properties-ready for use in the stroke clinic? Biomed Res Int. 2015
- Fu YQ, Zheng JS, Yang B, Li D. Effect of individual omega-3 fatty acids on the risk of prostate cancer: a systematic review and dose-response meta-analysis of prospective cohort studies. J Epidemiol. 2015
- Li D. Omega-3 polyunsaturated fatty acids and non-communicable diseases: meta-analysis based systematic review. Asia Pac J Clin Nutr. 2015
- Saccone G, Berghella V. Omega-3 long chain polyunsaturated fatty acids to prevent preterm birth: a systematic review and meta-analysis. Obstet Gynecol. 2015
- Patrick RP, Ames BN. Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior. FASEB J. 2015
- Skulas-Ray AC. Omega-3 fatty acids and inflammation: a perspective on the challenges of evaluating efficacy in clinical research. Prostaglandins Other Lipid Mediat. 2015
- Miyata J, Arita M. Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases. Allergol Int. 2015
- Weintraub HS. Overview of prescription omega-3 fatty acid products for hypertriglyceridemia. Postgrad Med. 2014
- Alexander JW, Supp DM. Role of Arginine and Omega-3 Fatty Acids in Wound Healing and Infection. Adv Wound Care (New Rochelle). 2014
- Park JM, Kwon SH, Han YM, Hahm KB, Kim EH. Omega-3 polyunsaturated Fatty acids as potential chemopreventive agent for gastrointestinal cancer. J Cancer Prev. 2013
- Pacifico L, Giansanti S, Gallozzi A, Chiesa C. Long chain omega-3 polyunsaturated fatty acids in pediatric metabolic syndrome. Mini Rev Med Chem. 2014
- Küllenberg de Gaudry D, Massing U. [Importance of long chain omega-3 fatty acids in prostate cancer]. Urologe A. 2014
- Superko HR, Superko AR, Lundberg GP, Margolis B, Garrett BC, Nasir K, Agatston AS. Omega-3 Fatty Acid Blood Levels Clinical Significance Update. Curr Cardiovasc Risk Rep. 2014
- Guichardant M, Calzada C, Bernoud-Hubac N, Lagarde M, Véricel E. Omega-3 polyunsaturated fatty acids and oxygenated metabolism in atherothrombosis. Biochim Biophys Acta. 2015
- De Mel D, Suphioglu C. Fishy business: effect of omega-3 fatty acids on zinc transporters and free zinc availability in human neuronal cells. Nutrients. 2014
- Calder PC. Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochim Biophys Acta. 2015
- Patterson WL 3rd, Georgel PT. Breaking the cycle: the role of omega-3 polyunsaturated fatty acids in inflammation-driven cancers. Biochem Cell Biol. 2014
- Davidson MH, Phillips AK, Kling D, Maki KC. Addition of omega-3 carboxylic acids to statin therapy in patients with persistent hypertriglyceridemia. Expert Rev Cardiovasc Ther. 2014
- Oh da Y, Walenta E. Omega-3 Fatty Acids and FFAR4. Front Endocrinol (Lausanne). 2014
- Mori TA. Omega-3 fatty acids and cardiovascular disease: epidemiology and effects on cardiometabolic risk factors. Food Funct. 2014
- Gow RV, Hibbeln JR. Omega-3 fatty acid and nutrient deficits in adverse neurodevelopment and childhood behaviors. Child Adolesc Psychiatr Clin N Am. 2014
- Zhang P, Lavoie PM, Lacaze-Masmonteil T, Rhainds M, Marc I. Omega-3 long-chain polyunsaturated fatty acids for extremely preterm infants: a systematic review. Pediatrics. 2014
- Malhotra A, Shafiq N, Arora A, Singh M, Kumar R, Malhotra S. Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia. Cochrane Database Syst Rev. 2014
- Chen W, Jiang H, Zhou ZY, Tao YX, Cai B, Liu J, Yang H, Lu CD, Zeng J. Is omega-3 fatty acids enriched nutrition support safe for critical ill patients? A systematic review and meta-analysis. Nutrients. 2014
- Enns JE, Yeganeh A, Zarychanski R, Abou-Setta AM, Friesen C, Zahradka P, Taylor CG. The impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2014
- Kumar PR, Essa MM, Al-Adawi S, Dradekh G, Memon MA, Akbar M, Manivasagam T. Omega-3 Fatty acids could alleviate the risks of traumatic brain injury - a mini review. J Tradit Complement Med. 2014
- Barrett EC, McBurney MI, Ciappio ED. ω-3 fatty acid supplementation as a potential therapeutic aid for the recovery from mild traumatic brain injury/concussion. Adv Nutr. 2014
- D'Auria E, Miraglia Del Giudice M, Barberi S, Mandelli M, Verduci E, Leonardi S, Riva E, Giovannini M. Omega-3 fatty acids and asthma in children. Allergy Asthma Proc. 2014
- Hashimoto M. [Omega-3 fatty acids and cognition]. Nihon Rinsho. 2014
- Grosso G, Galvano F, Marventano S, Malaguarnera M, Bucolo C, Drago F, Caraci F. Omega-3 fatty acids and depression: scientific evidence and biological mechanisms. Oxid Med Cell Longev. 2014
- McLennan PL. Cardiac physiology and clinical efficacy of dietary fish oil clarified through cellular mechanisms of omega-3 polyunsaturated fatty acids. Eur J Appl Physiol. 2014
- Guo XY, Yan XL, Chen YW, Tang RB, Du X, Dong JZ, Ma CS. Omega-3 fatty acids for postoperative atrial fibrillation: alone or in combination with antioxidant vitamins? Heart Lung Circ. 2014
- de Lorgeril M, Salen P. Helping women to good health: breast cancer, omega-3/omega-6 lipids, and related lifestyle factors. BMC Med. 2014
- Barros MP, Poppe SC, Bondan EF. Neuroprotective properties of the marine carotenoid astaxanthin and omega-3 fatty acids, and perspectives for the natural combination of both in krill oil. Nutrients. 2014
- Querques G, Souied EH. The role of omega-3 and micronutrients in age-related macular degeneration. Surv Ophthalmol. 2014
- Marai I, Massalha S. Effect of omega-3 polyunsaturated fatty acids and vitamin D on cardiovascular diseases. Isr Med Assoc J. 2014
- Gumpricht E, Rockway S. Can ω-3 fatty acids and tocotrienol-rich vitamin E reduce symptoms of neurodevelopmental disorders? Nutrition. 2014
- Reiner MF, Stivala S, Camici GG, Beer JH. [The effects of Omega-3 fatty acids in clinical medicine]. Praxis (Bern 1994). 2014
- Adarme-Vega TC, Thomas-Hall SR, Schenk PM. Towards sustainable sources for omega-3 fatty acids production. Curr Opin Biotechnol. 2014
- Mo Y, Hu X, Chang L, Ma P. [The effect of ω-3 fatty acid supplementation in parenteral nutrition on the outcome of patients with sepsis: a systematic review and meta-analysis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014
- Lev-Tzion R, Griffiths AM, Leder O, Turner D. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2014
- Zhu D, Zhang Y, Li S, Gan L, Feng H, Nie W. Enteral omega-3 fatty acid supplementation in adult patients with acute respiratory distress syndrome: a systematic review of randomized controlled trials with meta-analysis and trial sequential analysis. Intensive Care Med. 2014
- Di Girolamo FG, Situlin R, Mazzucco S, Valentini R, Toigo G, Biolo G. Omega-3 fatty acids and protein metabolism: enhancement of anabolic interventions for sarcopenia. Curr Opin Clin Nutr Metab Care. 2014
- Kar S. Role of omega-3 fatty acids in the prevention of atrial fibrillation. Rev Cardiovasc Med. 2013
- Giles GE, Mahoney CR, Kanarek RB. Omega-3 fatty acids influence mood in healthy and depressed individuals. Nutr Rev. 2013
- Hennebelle M, Champeil-Potokar G, Lavialle M, Vancassel S, Denis I. Omega-3 polyunsaturated fatty acids and chronic stress-induced modulations of glutamatergic neurotransmission in the hippocampus. Nutr Rev. 2014
- Fares H, Lavie CJ, DiNicolantonio JJ, O'Keefe JH, Milani RV. Omega-3 fatty acids: a growing ocean of choices. Curr Atheroscler Rep. 2014
- Kromhout D, de Goede J. Update on cardiometabolic health effects of ω-3 fatty acids. Curr Opin Lipidol. 2014
- Giordano E, Visioli F. Long-chain omega 3 fatty acids: molecular bases of potential antioxidant actions. Prostaglandins Leukot Essent Fatty Acids. 2014
- Silva V, Barazzoni R, Singer P. Biomarkers of fish oil omega-3 polyunsaturated fatty acids intake in humans. Nutr Clin Pract. 2014
- Bauer I, Crewther S, Pipingas A, Sellick L, Crewther D. Does omega-3 fatty acid supplementation enhance neural efficiency? A review of the literature. Hum Psychopharmacol. 2014
- Oliver C, Watson H. Omega-3 fatty acids for cystic fibrosis. Cochrane Database Syst Rev. 2013
- D'Souza V, Chavan-Gautam P, Joshi S. Counteracting oxidative stress in pregnancy through modulation of maternal micronutrients and omega-3 fatty acids. Curr Med Chem. 2013
- Michael-Titus AT, Priestley JV. Omega-3 fatty acids and traumatic neurological injury: from neuroprotection to neuroplasticity? Trends Neurosci. 2014
- Lane K, Derbyshire E, Li W, Brennan C. Bioavailability and potential uses of vegetarian sources of omega-3 fatty acids: a review of the literature. Crit Rev Food Sci Nutr. 2014
- Cederholm T, Salem N Jr, Palmblad J. ω-3 fatty acids in the prevention of cognitive decline in humans. Adv Nutr. 2013
- Yamagishi K, Hori M, Iso H. [Fish and omega-3 polyunsaturated fatty acids in relation to risk of cardiovascular disease]. Nihon Rinsho. 2013
- Yates CM, Calder PC, Ed Rainger G. Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease. Pharmacol Ther. 2014
- Harris WS, Dayspring TD, Moran TJ. Omega-3 fatty acids and cardiovascular disease: new developments and applications. Postgrad Med. 2013
- Superko HR, Superko SM, Nasir K, Agatston A, Garrett BC. Omega-3 fatty acid blood levels: clinical significance and controversy. Circulation. 2013
- Ganesan B, Brothersen C, McMahon DJ. Fortification of foods with omega-3 polyunsaturated fatty acids. Crit Rev Food Sci Nutr. 2014
- Davidson MH. Omega-3 fatty acids: new insights into the pharmacology and biology of docosahexaenoic acid, docosapentaenoic acid, and eicosapentaenoic acid. Curr Opin Lipidol. 2013
- Fenton JI, Hord NG, Ghosh S, Gurzell EA. Immunomodulation by dietary long chain omega-3 fatty acids and the potential for adverse health outcomes. Prostaglandins Leukot Essent Fatty Acids. 2013
- Bouzianas DG, Bouziana SD, Hatzitolios AI. Potential treatment of human nonalcoholic fatty liver disease with long-chain omega-3 polyunsaturated fatty acids. Nutr Rev. 2013
- Gray B, Steyn F, Davies PS, Vitetta L. Omega-3 fatty acids: a review of the effects on adiponectin and leptin and potential implications for obesity management. Eur J Clin Nutr. 2013
- Flock MR, Harris WS, Kris-Etherton PM. Long-chain omega-3 fatty acids: time to establish a dietary reference intake. Nutr Rev. 2013
- Su KP, Wang SM, Pae CU. Omega-3 polyunsaturated fatty acids for major depressive disorder. Expert Opin Investig Drugs. 2013
- Weintraub H. Update on marine omega-3 fatty acids: management of dyslipidemia and current omega-3 treatment options. Atherosclerosis. 2013
- Christou GA, Rizos EC, Mpechlioulis A, Penzo C, Pacchioni A, Nikas DN. Confronting the residual cardiovascular risk beyond statins: the role of fibrates, omega-3 fatty acids, or niacin, in diabetic patients. Curr Pharm Des. 2014
- Barrett SJ. The role of omega-3 polyunsaturated fatty acids in cardiovascular health. Altern Ther Health Med. 2013
- Casula M, Soranna D, Catapano AL, Corrao G. Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials [corrected]. Atheroscler Suppl. 2013
- Pirillo A, Catapano AL. Omega-3 polyunsaturated fatty acids in the treatment of atherogenic dyslipidemia. Atheroscler Suppl. 2013
- Jing K, Wu T, Lim K. Omega-3 polyunsaturated fatty acids and cancer. Anticancer Agents Med Chem. 2013
- Simopoulos AP. Dietary omega-3 fatty acid deficiency and high fructose intake in the development of metabolic syndrome, brain metabolic abnormalities, and non-alcoholic fatty liver disease. Nutrients. 2013
- Scorletti E, Byrne CD. Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease. Annu Rev Nutr. 2013
- Pirillo A, Catapano AL. Omega-3 polyunsaturated fatty acids in the treatment of hypertriglyceridaemia. Int J Cardiol. 2013
- Campbell A, Price J, Hiatt WR. Omega-3 fatty acids for intermittent claudication. Cochrane Database Syst Rev. 2013
- Lorente-Cebrián S, Costa AG, Navas-Carretero S, Zabala M, MartÃnez JA, Moreno-Aliaga MJ. Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence. J Physiol Biochem. 2013
- Gu Z, Suburu J, Chen H, Chen YQ. Mechanisms of omega-3 polyunsaturated fatty acids in prostate cancer prevention. Biomed Res Int. 2013
- McDonald C, Bauer J, Capra S. Omega-3 fatty acids and changes in LBM: alone or in synergy for better muscle health? Can J Physiol Pharmacol. 2013
- Landmark K, Alm CS. [Fish and omega-3 fatty acids and heart failure]. Tidsskr Nor Laegeforen. 2012
- Billman GE. The effects of omega-3 polyunsaturated fatty acids on cardiac rhythm: a critical reassessment. Pharmacol Ther. 2013
- Miles EA, Calder PC. Omega-6 and omega-3 polyunsaturated fatty acids and allergic diseases in infancy and childhood. Curr Pharm Des. 2014
- Schuchardt JP, Hahn A. Bioavailability of long-chain omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2013
- Chang CL, Deckelbaum RJ. Omega-3 fatty acids: mechanisms underlying 'protective effects' in atherosclerosis. Curr Opin Lipidol. 2013
- Flock MR, Rogers CJ, Prabhu KS, Kris-Etherton PM. Immunometabolic role of long-chain omega-3 fatty acids in obesity-induced inflammation. Diabetes Metab Res Rev. 2013
- Levant B. N-3 (omega-3) polyunsaturated Fatty acids in the pathophysiology and treatment of depression: pre-clinical evidence. CNS Neurol Disord Drug Targets. 2013
- Kang JX, Gleason ED. Omega-3 Fatty acids and hippocampal neurogenesis in depression. CNS Neurol Disord Drug Targets. 2013
- Ciccone MM, Scicchitano P, Gesualdo M, Zito A, Carbonara S, Ricci G, Cortese F, Giordano P. The role of omega-3 polyunsaturated fatty acids supplementation in childhood: a review. Recent Pat Cardiovasc Drug Discov. 2013
- Mischoulon D, Freeman MP. Omega-3 fatty acids in psychiatry. Psychiatr Clin North Am. 2013
- Rahman M, Beg S, Ahmad MZ, Kazmi I, Ahmed A, Rahman Z, Ahmad FJ, Akhter S. Omega-3 fatty acids as pharmacotherapeutics in psoriasis: current status and scope of nanomedicine in its effective delivery. Curr Drug Targets. 2013
- Maskrey BH, Megson IL, Rossi AG, Whitfield PD. Emerging importance of omega-3 fatty acids in the innate immune response: molecular mechanisms and lipidomic strategies for their analysis. Mol Nutr Food Res. 2013
- Minihane AM. Fish oil omega-3 fatty acids and cardio-metabolic health, alone or with statins. Eur J Clin Nutr. 2013
- Mickleborough TD. Omega-3 polyunsaturated fatty acids in physical performance optimization. Int J Sport Nutr Exerc Metab. 2013
- Denis I, Potier B, Vancassel S, Heberden C, Lavialle M. Omega-3 fatty acids and brain resistance to ageing and stress: body of evidence and possible mechanisms. Ageing Res Rev. 2013
- Hasadsri L, Wang BH, Lee JV, Erdman JW, Llano DA, Barbey AK, Wszalek T, Sharrock MF, Wang HJ. Omega-3 fatty acids as a putative treatment for traumatic brain injury. J Neurotrauma. 2013
- Jeppesen C, Schiller K, Schulze MB. Omega-3 and omega-6 fatty acids and type 2 diabetes. Curr Diab Rep. 2013
- Lenox CE, Bauer JE. Potential adverse effects of omega-3 Fatty acids in dogs and cats. J Vet Intern Med. 2013
- Gerber PA, Gouni-Berthold I, Berneis K. Omega-3 fatty acids: role in metabolism and cardiovascular disease. Curr Pharm Des. 2013
- Laviano A, Rianda S, Molfino A, Rossi Fanelli F. Omega-3 fatty acids in cancer. Curr Opin Clin Nutr Metab Care. 2013
- Kimmig LM, Karalis DG. Do omega-3 polyunsaturated Fatty acids prevent cardiovascular disease? A review of the randomized clinical trials. Lipid Insights. 2013
- Rix TA, Christensen JH, Schmidt EB. Omega-3 fatty acids and cardiac arrhythmias. Curr Opin Clin Nutr Metab Care. 2013
- Lawrenson JG, Evans JR. Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev. 2012
- Di Minno MN, Russolillo A, Lupoli R, Ambrosino P, Di Minno A, Tarantino G. Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease. World J Gastroenterol. 2012
- Palmer AJ, Ho CK, Ajibola O, Avenell A. The role of ω-3 fatty acid supplemented parenteral nutrition in critical illness in adults: a systematic review and meta-analysis. Crit Care Med. 2013
- Chowdhury R, Stevens S, Gorman D, Pan A, Warnakula S, Chowdhury S, Ward H, Johnson L, Crowe F, Hu FB, Franco OH. Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis. BMJ. 2012
- Kotwal S, Jun M, Sullivan D, Perkovic V, Neal B. Omega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2012
- Kang JX, Liu A. The role of the tissue omega-6/omega-3 fatty acid ratio in regulating tumor angiogenesis. Cancer Metastasis Rev. 2013
- Siegel G, Ermilov E. Omega-3 fatty acids: benefits for cardio-cerebro-vascular diseases. Atherosclerosis. 2012
- Kromhout D. Omega-3 fatty acids and coronary heart disease. The final verdict? Curr Opin Lipidol. 2012
- Cao H, Wang X, Huang H, Ying SZ, Gu YW, Wang T, Huang CX. Omega-3 fatty acids in the prevention of atrial fibrillation recurrences after cardioversion: a meta-analysis of randomized controlled trials. Intern Med. 2012
- Jump DB, Depner CM, Tripathy S. Omega-3 fatty acid supplementation and cardiovascular disease. J Lipid Res. 2012
- Luchtman DW, Song C. Cognitive enhancement by omega-3 fatty acids from child-hood to old age: findings from animal and clinical studies. Neuropharmacology. 2013
- Moore MR, King RA. Effects of omega-3 fatty acids on progestin stimulation of invasive properties in breast cancer. Horm Cancer. 2012
- Calder PC. The role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability. Mol Nutr Food Res. 2012
- Eckert GP, Lipka U, Muller WE. Omega-3 fatty acids in neurodegenerative diseases: focus on mitochondria. Prostaglandins Leukot Essent Fatty Acids. 2013
- Turchini GM, Nichols PD, Barrow C, Sinclair AJ. Jumping on the omega-3 bandwagon: distinguishing the role of long-chain and short-chain omega-3 fatty acids. Crit Rev Food Sci Nutr. 2012
- Williams K, Marraffa C. No evidence yet to support omega-3 fatty acids as a treatment for autism. J Paediatr Child Health. 2012
- Djoussé L, Akinkuolie AO, Wu JH, Ding EL, Gaziano JM. Fish consumption, omega-3 fatty acids and risk of heart failure: a meta-analysis. Clin Nutr. 2012
- He Z, Yang L, Tian J, Yang K, Wu J, Yao Y. Efficacy and safety of omega-3 fatty acids for the prevention of atrial fibrillation: a meta-analysis. Can J Cardiol. 2013
- Khawaja O, Gaziano JM, Djoussé L. A meta-analysis of omega-3 fatty acids and incidence of atrial fibrillation. J Am Coll Nutr. 2012
- Serra-Majem L, Nissensohn M, Øverby NC, Fekete K. Dietary methods and biomarkers of omega 3 fatty acids: a systematic review. Br J Nutr. 2012
- Ortega RM, RodrÃguez-RodrÃguez E, López-Sobaler AM. Effects of omega 3 fatty acids supplementation in behavior and non-neurodegenerative neuropsychiatric disorders. Br J Nutr. 2012
- Orchard TS, Pan X, Cheek F, Ing SW, Jackson RD. A systematic review of omega-3 fatty acids and osteoporosis. Br J Nutr. 2012
- Cabré E, Mañosa M, Gassull MA. Omega-3 fatty acids and inflammatory bowel diseases - a systematic review. Br J Nutr. 2012
- Tur JA, Bibiloni MM, Sureda A, Pons A. Dietary sources of omega 3 fatty acids: public health risks and benefits. Br J Nutr. 2012
- Gerber M. Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies. Br J Nutr. 2012
- Wu JH, Micha R, Imamura F, Pan A, Biggs ML, Ajaz O, Djousse L, Hu FB, Mozaffarian D. Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis. Br J Nutr. 2012
- Delgado-Lista J, Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F. Long chain omega-3 fatty acids and cardiovascular disease: a systematic review. Br J Nutr. 2012
- Cabo J, Alonso R, Mata P. Omega-3 fatty acids and blood pressure. Br J Nutr. 2012
- Rangel-Huerta OD, Aguilera CM, Mesa MD, Gil A. Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomakers: a systematic review of randomised clinical trials. Br J Nutr. 2012
- Dangour AD, Andreeva VA, Sydenham E, Uauy R. Omega 3 fatty acids and cognitive health in older people. Br J Nutr. 2012
- Ubeda N, Achón M, Varela-Moreiras G. Omega 3 fatty acids in the elderly. Br J Nutr. 2012
- de Lorgeril M, Salen P. New insights into the health effects of dietary saturated and omega-6 and omega-3 polyunsaturated fatty acids. BMC Med. 2012
- Calder PC, Yaqoob P. Marine omega-3 fatty acids and coronary heart disease. Curr Opin Cardiol. 2012
- Oh DY, Olefsky JM. Omega 3 fatty acids and GPR120. Cell Metab. 2012
- Im DS. Omega-3 fatty acids in anti-inflammation (pro-resolution) and GPCRs. Prog Lipid Res. 2012
- Carpentier YA, Portois L, Malaisse WJ. Rapid enrichment of cell phospholipids in long-chain polyunsaturated ω-3 fatty acids after a bolus intravenous injection of a medium-chain triacylglycerol: fish oil emulsion in humans. JPEN J Parenter Enteral Nutr. 2012
- Burillo E, MartÃn-Fuentes P, Mateo-Gallego R, Baila-Rueda L, Cenarro A, Ros E, Civeira F. Omega-3 fatty acids and HDL. How do they work in the prevention of cardiovascular disease? Curr Vasc Pharmacol. 2012
- Swanson D, Block R, Mousa SA. Omega-3 fatty acids EPA and DHA: health benefits throughout life. Adv Nutr. 2012
- Mozurkewich EL, Klemens C. Omega-3 fatty acids and pregnancy: current implications for practice. Curr Opin Obstet Gynecol. 2012
- Weylandt KH, Chiu CY, Gomolka B, Waechter SF, Wiedenmann B. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. Prostaglandins Other Lipid Mediat. 2012
- Wang Q, Liang X, Wang L, Lu X, Huang J, Cao J, Li H, Gu D. Effect of omega-3 fatty acids supplementation on endothelial function: a meta-analysis of randomized controlled trials. Atherosclerosis. 2012
- Papazafiropoulou AK, Kardara MS, Pappas SI. Pleiotropic effects of omega-3 fatty acids. Recent Pat Endocr Metab Immune Drug Discov. 2012
- Lewis MD, Bailes J. Neuroprotection for the warrior: dietary supplementation with omega-3 fatty acids. Mil Med. 2011
- James S, Montgomery P, Williams K. Omega-3 fatty acids supplementation for autism spectrum disorders (ASD). Cochrane Database Syst Rev. 2011
- Dennehy C. Omega-3 fatty acids and ginger in maternal health: pharmacology, efficacy, and safety. J Midwifery Womens Health. 2011
- Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol. 2011
- Kar S. Omacor and omega-3 fatty acids for treatment of coronary artery disease and the pleiotropic effects. Am J Ther. 2014
- Gören JL, Tewksbury AT. The use of omega-3 fatty acids in mental illness. J Pharm Pract. 2011
- Kromhout D, Yasuda S, Geleijnse JM, Shimokawa H. Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work? Eur Heart J. 2012
- Bloch MH, Hannestad J. Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis. Mol Psychiatry. 2012
- Dyall SC. Methodological issues and inconsistencies in the field of omega-3 fatty acids research. Prostaglandins Leukot Essent Fatty Acids. 2011
- Gillies PJ, Harris WS, Kris-Etherton PM. Omega-3 fatty acids in food and pharma: the enabling role of biotechnology. Curr Atheroscler Rep. 2011
- McNamara RK. Long-chain omega-3 fatty acid deficiency in mood disorders: rationale for treatment and prevention. Curr Drug Discov Technol. 2013
- Balanzá-MartÃnez V, Fries GR, Colpo GD, Silveira PP, Portella AK, Tabarés-Seisdedos R, Kapczinski F. Therapeutic use of omega-3 fatty acids in bipolar disorder. Expert Rev Neurother. 2011
- Hegarty BD, Parker GB. Marine omega-3 fatty acids and mood disorders--linking the sea and the soul. 'Food for Thought' I. Acta Psychiatr Scand. 2011
- Bousquet M, Calon F, Cicchetti F. Impact of ω-3 fatty acids in Parkinson's disease. Ageing Res Rev. 2011
- Shapiro H, Tehilla M, Attal-Singer J, Bruck R, Luzzatti R, Singer P. The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease. Clin Nutr. 2011
Article last updated on: March 13th, 2018 by Nootriment
1 Comment
currently I’m taking Omega-3 fatty acid -EPA -90mg & DHA -60mg per day.
In addition to that planning to take Alpha GPC -400mg capsule.
can I proceed with this dose plan?